Assessment of Senl_B19 CAR-T Cells in Relapsed/Refractory CD19+ B-ALL
Clinical trial NCT07244406 · RECRUITING
Trial details
- NCT number
- NCT07244406
- Sponsor
- Hebei Senlang Biotechnology Inc., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-10
- Primary completion
- 2027-03-31
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.